- Series: A
- Co-Investors: Accel, Ocean Azul Partners, Seraph Ventures
- Date of Investment: February 2023
- Investment Amount: $2,000,000
- Summary: Digbi Health is a precision health platform utilizing AI to harness genetic, gut microbiome, and behavioral signals to target the root cause and provide virtual care to people living with polychronic physical and mental illness associated with inflammatory gut and weight. Digbi delivers tailored whole-person care, including remote monitoring, food-as-medicine, pharma reduction, behavioral coaching support, and care coordination.
- Product offering: Digbi has FDA authorization for addressing anxiety and depression linked to gut health. Digbi Health combines proven genetic science with powerful AI technology to offer personalized health programs based on an individual’s DNA, gut biome, and blood markers. Digbi Health provides two programs, Digbi Cares and GLP-Fit.
- Digbi Cares: Precision gut microbiome and genetics based digital care for weight-loss, diabetes, digestive health, hypertension and care support that identifies the root causes for ailments and comorbidities.
- GLP-Fit: Proprietary predictive engine to recommend anti-obesity medicine and the management of tapering off and weight “regain” management.
- Seven leading health plans have selected Digbi Health’s multi-condition care platform – Obesity, T2D/Cardiometabolic, GI – for their commercial clients – self-insured, fully insured, and Medicare populations. Partnerships set go live in January 2024.
- Employer client base expanded 10X in 2023 adding 70K contracted covered lives.
- Collaboration with Novo Nordisk has opened the potential for multi-million-dollar 2024 contracts with Novo and other pharmaceutical companies.
- Secured CDC DPP Full Plus recognition, enabling Medicare market entry.
- Granted two patents for innovation in precision biology to treat obesity and cardiometabolic diseases.
Potential Fund/ LG Acceleration: Our team is exploring opportunities for providing Digbi’s health solution through various LGE healthcare platforms being developed in addition to the potential for white-labeling the product. There may also be opportunities to introduce the product to key partners and large employer programs LGE works with in other capacities.
Digbi Health is a precision health platform utilizing AI to harness genetic, gut microbiome, and behavioral signals to target the root cause and provide virtual care to people living with polychronic physical and mental illness associated with inflammatory gut and weight. Digbi delivers tailored whole-person care, including remote monitoring, food-as-medicine, pharma reduction, behavioral coaching support, and care coordination.
